.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Dr. May's performance in the California market has shown notable trends across different categories. In the Tincture & Sublingual category, the brand experienced a gradual decline in rankings from 15th in March 2024 to 18th by June 2024. This drop is accompanied by a consistent decrease in sales, from $38,059 in March to $21,403 in June, indicating potential challenges in maintaining market share or consumer interest in this product line. On the other hand, the Topical category paints a more positive picture for Dr. May. The brand improved its ranking from 13th in March to 10th by June, with sales increasing steadily from $23,817 to $28,605. This upward trajectory suggests growing consumer acceptance and a stronger foothold in the Topical market.
It’s important to note that Dr. May did not appear in the top 30 brands in some states and categories, which could be indicative of either a strategic focus on specific markets or a need for improved market penetration strategies in those areas. For instance, the absence of rankings in other states or categories could be seen as a gap in the brand's overall market presence. The contrasting performance in California highlights the importance of regional strategies and the potential benefits of focusing on growing categories like Topical products. This mixed performance across different segments and regions underscores the dynamic nature of the cannabis market and the necessity for brands like Dr. May to continuously adapt and refine their strategies.
Competitive Landscape
In the competitive landscape of California's topical cannabis market, Dr. May has shown a notable upward trend in rank and sales over the past few months. Starting from a rank of 13 in March 2024, Dr. May has climbed to the 10th position by June 2024. This steady improvement highlights a positive trajectory, especially when compared to competitors like High Desert Pure, which experienced fluctuations, peaking at rank 8 in March but dropping to 12 in April before stabilizing at rank 9 in June. Similarly, Kush Queen maintained a consistent rank of 8 throughout the period, suggesting strong market presence but limited growth. Meanwhile, OM and Autumn Brands displayed more volatility, with OM dropping from rank 9 in April to 11 in June, and Autumn Brands falling from rank 10 in April to 12 in June. Dr. May's consistent rise in rank and sales, despite the competitive pressures, indicates a growing consumer preference and effective market strategies, positioning it as a brand to watch in the California topical cannabis market.
Notable Products
In June 2024, the top-performing product from Dr. May was the CBD/THC 1:1 Balance Pro Balm (500mg CBD, 500mg THC, 3.75oz, 110ml) in the Topical category, maintaining its consistent number one rank with sales of 274 units. The CBD/THC 1:20 Relax Twist Up Balm (5mg CBD, 100mg THC) also in the Topical category, held the second rank, showing an increase in sales from 190 units in May to 215 units in June. The CBD/THC 1:1 Balance Twist-Up Topical Balm (50mg CBD, 50mg THC, 1.5oz) debuted in the rankings at third place. In the Tincture & Sublingual category, the CBD:THC 1:20 Relax 1000 Formula Tincture (50mg CBD, 950mg THC, 30ml) dropped from third to fourth place, while the CBD:THC 1:20 Relax 350 Formula Tincture (17mg CBD, 333mg THC, 15ml, 1oz) remained steady at fifth place. Notably, the rankings for the top Topical products have shown stability, whereas the Tincture & Sublingual products have seen minor fluctuations.
Top Selling Cannabis Brands
